Home
About
Who we are
What we do
The rationale for AVRA
A robust vaccine pipeline
The global and national context
Expected benefits
Governance and management
Key Activities
Antigen surveillance
Vaccine platform technologies
Adjuvant development
Antigen discovery
Animal models
Vaccine immunity
Vaccine manufacturing partners
Clinical trials
Education and training
People
Partners
News and Events
Contact
Menu
CSL signs agreement with Australian Government for UQ vaccine supply
Sep 20, 2020
Infection and immunity masterclass series
Aug 28, 2020
UQ vaccine scientists report positive results from pre-clinical testing
Aug 26, 2020
The history of vaccines, from smallpox to SARS and beyond
Aug 26, 2020
What to expect from a COVID-19 vaccine
Aug 20, 2020
« Older Entries
Next Entries »
